Artisan Partners Limited Partnership Ascendis Pharma A/S Transaction History
Artisan Partners Limited Partnership
- $58.2 Billion
- Q1 2025
A detailed history of Artisan Partners Limited Partnership transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 4,256,627 shares of ASND stock, worth $833 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
4,256,627
Previous 4,450,420
4.35%
Holding current value
$833 Million
Previous $613 Million
8.28%
% of portfolio
1.14%
Previous 0.98%
Shares
28 transactions
Others Institutions Holding ASND
# of Institutions
280Shares Held
61.6MCall Options Held
202KPut Options Held
201K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$1.02 Billion13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$878 Million0.4% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.05MShares$598 Million0.31% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...